Endothelial progenitor cells as a cardiometabolic risk factor marker in prediabetes

Hormones

Volumn 13, Issue 2, 2014, Pages 244-251

  Angelidi, Angeliki ^a   Melidonis, Andreas ^a   Protopsaltis, Ioannis ^a   Sergentanis, Theodoros N ^b   Gritzapis, Angelos ^c   Kornezos, Ioannis ^a   Economopoulos, Theofanis ^d   Dimitriadis, George ^d   Boutati, Eleni ^d   Raptis, Sotirios A ^d,e  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Locus Medicus SA   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^e Hellenic National Center for the Research   (Greece)

Author keywords

Endothelial progenitor cells; Insulin resistance; Prediabetes; Visceral fat

Indexed keywords

ALDOSTERONE INHIBITOR; ANGIOTENSIN INHIBITOR; C REACTIVE PROTEIN; CD133 ANTIGEN; CD34 ANTIGEN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HORMONE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN INHIBITOR; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2; BIOLOGICAL MARKER; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; ECHOGRAPHY; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LOGISTIC REGRESSION ANALYSIS; MALE; MEAN ARTERIAL PRESSURE; MULTIVARIATE ANALYSIS; ORAL GLUCOSE TOLERANCE TEST; POST HOC ANALYSIS; SENSITIVITY ANALYSIS; SUBCUTANEOUS FAT; UNIVARIATE ANALYSIS; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ARTERIAL PRESSURE; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; ENDOTHELIUM CELL; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; PREDIABETIC STATE; RISK; RISK FACTOR; STATISTICAL MODEL; STEM CELL;

ADIPOSITY; ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD34; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; ENDOTHELIAL CELLS; FEMALE; GLYCOPROTEINS; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PEPTIDES; PREDIABETIC STATE; RISK FACTORS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84899660611     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401338     Document Type: Article

References (24)

1. American Diabetes Association, 2011 Diagnosis and classification of diabetes mellitus. Diabetes Care 34: Suppl 1: 62-69.
2. Laakso M, 2010 Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care 33: 442-449.
3. Davignon J, Ganz P, 2004 Role of endothelial dysfunction in atherosclerosis. Circulation 109: Suppl 1: II27-II32.
4. Asahara T, Murohara T, Sullivan A, et al, 1997 Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
5. Urbich C, Dimmeler S, 2004 Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353.
6. Schmidt-Lucke C, Rössig L, Fichtlscherer S, et al, 2005 Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987.
7. Werner N, Kosiol S, Schiegl T, et al, 2005 Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353: 999-1007.
8. Fadini G, Agostini C, Sartore S, Avogaro A, 2007 Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 194: 46-54.
9. Shantsila E, Watson T, Lip GY, 2007 Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 49: 741-752.
10. Fadini GP, Pucci L, Vanacore R, et al, 2007 Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 50: 2156-2163.
11. De Lucia Rolfe E, Sleigh A, Finucane FM, et al, 2010 Ultrasound measurements of visceral and subcutaneous abdominal thickness to predict abdominal adiposity among older men and women. Obesity (Silver Spring) 18: 625-631.
12. Matthews DR, Hosker JP, Rudenski AS, et al, 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
13. Thomas HE, Avery PJ, Ahmed JM, et al, 2009 Local vessel injury following percutaneous coronary intervention does not promote early mobilization of endothelial progenitor cells in the absence of myocardial infarction. Heart 95: 555-558.
14. Sutherland DR, Nayyar R, Acton E, et al, 2009 Comparison of two single-platform ISHAGE-based CD34 enumeration protocols on BD FACSCalibur and FACSCanto flow cytometers. Cytotherapy 11: 595-605.
15. Fadini GP, Boscaro E, de Kreutzenberg S, et al, 2010 Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care 33: 1097-1102.
16. Dimmeler S, Aicher A, Vasa M, et al, 2001 HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397.
17. Desouza CV, Hamel FG, Bidasee K, O'Connell K, 2011 Role of inflammation and insulin resistance in endothelial progenitor cell dysfunction. Diabetes 60: 1286-1294.
18. Seeger FH, Haendeler J, Walter DH, et al, 2005 P38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111: 1184-1191.
19. Verma S, Kuliszewski MA, Li SH, et al, 2004 Creactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109: 2058-2067.
20. Chang J, Li Y, Huang Y, et al, 2010 Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 MAP kinase/p16INK4A signaling pathway. Diabetes 59: 2949-2959.
21. Biasucci LM, Graziani F, Rizzello V, et al, 2010 Paradoxical preservation of vascular function in severe obesity. Am J Med 123: 727-734.
22. Yue WS, Lau KK, Siu CW, et al, 2011 Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 10: 113.
23. Stolk RP, Wink O, Zelissen PM, Meijer R, van Gils AP, Grobbee DE, 2001 Validity and reproducibility of ultrasonography for the measurement of intra-abdominal adipose tissue. Int J Obes Relat Metab Disord 25: 1346-1351.
24. Armellini F, Zamboni M, Robbi R, et al, 1993 Total and intra-abdominal fat measurements by ultrasound and computerized tomography. Int J Obes Relat Metab Disord 17: 209-214.